Ignite Creation Date:
2024-05-05 @ 5:25 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00455910
Status:
COMPLETED
Last Update Posted:
2007-04-04
First Post:
2007-04-03
Brief Title:
Thalidomide at Low Dose for the Treatment of Patient With Myelodysplastic Syndromes - THAL-SMD-200
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Groupe Francophone des Myelodysplasies
Organization Data
Organization:
Groupe Francophone des Myelodysplasies
Class:
OTHER
Study ID:
020895
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Groupe Francophone des Myelodysplasies
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None